Boston, MA, United States of America

Christopher J H Davitt

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Evelo Biosciences, Inc.. Active years: 2021-2024.

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 3.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Christopher J H Davitt: Innovator in Bacterial Extracellular Vesicles

Introduction

Christopher J H Davitt is a notable inventor based in Boston, MA. He has made significant contributions to the field of biotechnology, particularly in the area of bacterial extracellular vesicles. With a total of 3 patents to his name, Davitt is recognized for his innovative approaches to therapeutic agents.

Latest Patents

Davitt's latest patents focus on bacterial extracellular vesicles. He has developed methods and compositions related to these vesicles, which are useful as therapeutic agents. His work in this area has the potential to advance medical treatments and improve patient outcomes.

Career Highlights

Currently, Christopher J H Davitt is associated with Evelo Biosciences, Inc. His role at the company allows him to further explore and develop his innovative ideas in biotechnology. His expertise and dedication to research have positioned him as a key figure in his field.

Collaborations

Davitt collaborates with talented individuals such as Baundauna Bose and Brian Goodman. These partnerships enhance the research and development efforts at Evelo Biosciences, Inc., fostering a collaborative environment that drives innovation.

Conclusion

Christopher J H Davitt is a prominent inventor whose work in bacterial extracellular vesicles is paving the way for new therapeutic solutions. His contributions to biotechnology are noteworthy, and his ongoing research promises to make a significant impact in the medical field.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…